129 related articles for article (PubMed ID: 12828586)
1. Piperacillin plus aztreonam for treatment of neutropenic fever.
Takeuchi M; Tanizawa A; Mayumi M
Pediatr Int; 2003 Jun; 45(3):307-10. PubMed ID: 12828586
[TBL] [Abstract][Full Text] [Related]
2. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
[TBL] [Abstract][Full Text] [Related]
3. Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy.
Fishman A; Chowers M; Altaras M; Beyth Y; Lang R
Eur J Gynaecol Oncol; 1998; 19(2):126-9. PubMed ID: 9611050
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
[TBL] [Abstract][Full Text] [Related]
5. Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients.
Fleischhack G; Schmidt-Niemann M; Wulff B; Havers W; Marklein G; Hasan C; Bode U
Support Care Cancer; 2001 Jul; 9(5):372-9. PubMed ID: 11497392
[TBL] [Abstract][Full Text] [Related]
6. [Aztreonam or gentamicin combined with piperacillin as empiric antibiotic therapy during neutropenia of patients with hematologic diseases].
Murase T
Kansenshogaku Zasshi; 1992 Feb; 66(2):121-6. PubMed ID: 1402071
[TBL] [Abstract][Full Text] [Related]
7. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
[TBL] [Abstract][Full Text] [Related]
8. Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin.
Heney D; Lewis IJ; Ghoneim AT; Chisholm P; Bailey CC
J Antimicrob Chemother; 1991 Jul; 28(1):117-29. PubMed ID: 1769930
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
Fouyssac F; Salmon A; Mansuy L; Schmitt C; Bordigoni P; Chastagner P
Med Mal Infect; 2005 Jun; 35(6):357-62. PubMed ID: 15982848
[TBL] [Abstract][Full Text] [Related]
10. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Hamidah A; Rizal AM; Nordiah AJ; Jamal R
Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765
[TBL] [Abstract][Full Text] [Related]
12. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.
Corapcioglu F; Sarper N; Zengin E
Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534
[TBL] [Abstract][Full Text] [Related]
13. Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.
Jones P; Rolston K; Fainstein V; Elting L; Bodey GP
Rev Infect Dis; 1985; 7 Suppl 4():S741-6. PubMed ID: 3909332
[TBL] [Abstract][Full Text] [Related]
14. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
Sanz MA; López J; Lahuerta JJ; Rovira M; Batlle M; Pérez C; Vázquez L; Julià A; Palau J; Gutiérrez M; Capote FJ; Ramos F; Benlloch L; Larrea L; Jarque I;
J Antimicrob Chemother; 2002 Jul; 50(1):79-88. PubMed ID: 12096010
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
Hirotsu T; Akatsuka J; Hoshi Y; Uchiyama H; Fujisawa K; Kobayashi N; Ishidoya N; Ohira M; Takayama J; Ishida Y
Jpn J Antibiot; 1990 Dec; 43(12):2069-77. PubMed ID: 2086821
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.
Bodey G; Reuben A; Elting L; Kantarjian H; Keating M; Hagemeister F; Koller C; Velasquez W; Papadopoulos N
Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):551-8. PubMed ID: 1915397
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
Feliu J; Artal A; González Barón M; Berrocal A; Chacón I; García de Paredes ML; Espinosa E; Ordóñez A; Zamora P; Montero JM
Antimicrob Agents Chemother; 1992 Dec; 36(12):2816-20. PubMed ID: 1482151
[TBL] [Abstract][Full Text] [Related]
19. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
[TBL] [Abstract][Full Text] [Related]
20. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Hess U; Böhme C; Rey K; Senn HJ
Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
